Your browser doesn't support javascript.
loading
Pluripotent stem cell-derived CD19-CAR iT cells effectively eradicate B-cell lymphoma in vivo.
Lv, Cui; Chen, Shoubing; Hu, Fangxiao; Huang, Dehao; Wang, Tongjie; Du, Juan; Wang, Jinyong; Wu, Hongling.
Afiliación
  • Lv C; School of Life Sciences, University of Science and Technology of China, Hefei, China.
  • Chen S; CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Hu F; Guangdong Provincial Key Laboratory of Stem cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Huang D; School of Life Sciences, University of Science and Technology of China, Hefei, China.
  • Wang T; CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Du J; Guangdong Provincial Key Laboratory of Stem cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Wang J; School of Life Sciences, University of Science and Technology of China, Hefei, China.
  • Wu H; CAS Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Cell Mol Immunol ; 18(3): 773-775, 2021 03.
Article en En | MEDLINE | ID: mdl-32541834
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B / Antígenos CD19 / Células Madre Pluripotentes Límite: Animals Idioma: En Revista: Cell Mol Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B / Antígenos CD19 / Células Madre Pluripotentes Límite: Animals Idioma: En Revista: Cell Mol Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: China